Renew Bioscience

Renew Bioscience is a private U.S. medical technology company focused on clinically advancing and distributing non-drug technologies intended to improve cardiovascular, neurological, and overall anatomical functionality and wellness. The company is best known for Cerezen, a drug-free, non-invasive device that uses external counterpulsation therapy to improve cerebral vascular health and was granted FDA Breakthrough Device Designation for Mild Cognitive Impairment due to Alzheimer's Disease and mild Alzheimer's dementia. Publicly available descriptions position the company as a commercial-stage med-tech business with activity spanning R&D, distribution, and related clinical studies. Available information suggests Renew Bioscience is more device-oriented than a traditional therapeutics biotech and does not appear to have a broad disclosed drug pipeline.